Lipigon is developing drugs for diseases caused by disruptions in the body's handling of lipids, where adequate treatment is currently lacking or limited, and where there is a significant unmet need for new and effective drugs.
Lipigon's drug development focuses on four drug projects. These projects have the potential, based on their mechanisms of action, to target broader indications, primarily in the field of blood lipids, their management, and associated diseases.
Lipigon aims to become a world-leading player in lipid-related diseases and the preferred collaborative partner for big pharma.
- Lipids, or fats, are biological materials that are not soluble in water and require other solvents.
- They are primarily composed of carbon and hydrogen atoms. Fats are energy-rich because their covalent bonds contain a lot of energy.
- There are different types of fats in the body, including triglycerides, phospholipids, fatty acids, steroids, sterols, waxes, fat-soluble vitamins, and hormones.
- Lipids have many important functions in the body. They form cell membranes, store energy reserves, act as hormones, provide insulation, and protect internal organs.